Time spent with residual viraemia after virological suppression below 50 HIV-RNA copies/mL according to type of first-line antiretroviral regimen

N Gianotti, L Galli, N Galizzi, M Ripa, A Andolina, S Nozza, V Spagnuolo, Andrea Poli, A Lazzarin, A Castagna

Research output: Contribution to journalArticle

Abstract

Purpose: To investigate if the regimen used when starting antiretroviral therapy (ART) affects the time spent with residual viraemia (RV) after achieving
Original languageEnglish
Pages (from-to)492-499
Number of pages8
JournalInternational Journal of Antimicrobial Agents
Volume52
Issue number4
DOIs
Publication statusPublished - 2018

Fingerprint Dive into the research topics of 'Time spent with residual viraemia after virological suppression below 50 HIV-RNA copies/mL according to type of first-line antiretroviral regimen'. Together they form a unique fingerprint.

  • Cite this